T he goal of scoliosis surgery is, first, to correct the deformity and, second, to achieve solid fusion of the correction obtained. The healing response of the spinal fusion is influenced by many variables, including host site conditions (decortication procedure, level of fusion, local blood supply), mechanical environment (instrumentation, stability), and graft bone conditions (source, type, amount of bone). 1 Currently, autogenous cancellous bone is the gold standard bone grafting material for spinal fusion. The most common site for harvesting autograft is the iliac crest. However, the use of autogenous bone graft is limited by the additional surgical time required to harvest the graft, the increased blood loss, the morbidity associated with the donor site, and the limited availability of cancellous bone. Bone graft substitutes are an alternative technique to enhance fusion rates.
A variety of bone graft substitutes are currently used in orthopaedic surgery including allograft bone, bioactive ceramic granules, beta-tricalcium phosphate, coralline hydroxyapatite, and osteogenic protein-1, with variable fusion success rates. 1Y4 In periodontology, use of a synthetic resorbable osteoconductive bone graft material composed of bioactive glass has recently been described, with high effectiveness in the treatment of intrabony defects. 5 Similarly, the material provided satisfactory bone healing in feline femoral defects. 6 To our knowledge, the ability of bioactive glass to achieve fusion in human spinal surgery has never been investigated. The purpose of this clinical and radiological study was to compare the effectiveness of bioactive glass and iliac crest autograft in the treatment of thoracic adolescent idiopathic scoliosis (AIS).
METHODS
Eighty-eight consecutive patients underwent posterior spinal fusion for progressive AIS between February 1998 and November 2003. All surgeries were performed by the same surgeon using the same instrumentation (SCS, Eurosurgical, 62217 Beaurains, France). The surgeon was assisted by a pediatric orthopaedic fellow. Segmental fixation with hybrid instrumentation (ie, pedicle screws at lumbar levels and hooks at thoracic levels) was used in all cases. In case of stiff thoracic curve (ie, reducibility under 50% on preoperative traction radiograph or supine bending films) or major loss of thoracic kyphosis (ie, thoracic kyphosis under 15 degrees), anterior release through thoracoscopy was performed first. During that procedure, the apex of the deformity and 2 disks above and below that level were released. fusion. Thoracoplasty was associated in all cases, but the bone from thoracoplasty was not kept for posterior fusion.
Posterior fusion was performed 3 or 4 days later. During the posterior procedures, spinal cord function was monitored by means of somatosensory/motor-evoked potentials, but no Stagnara wake-up test was used. Autotransfusion was performed with blood collected both preoperatively and intraoperatively.
The study patients were divided into 2 groups based on the type of bone graft used. The method of grafting depended only on when the patient was referred and the type of graft used at that time. We retrospectively studied the sequential use of 2 methods of bone grafting. Patients operated on between January 1998 and April 2001 received autograft harvested from the iliac crest, whereas those operated on from May 2001 to December 2003 received 15 cm 3 of bioglass (Novabone, Novabone Products, Alachua, Fla) hydrated by the patient_s blood (Fig. 1) .
With the patient in a prone position, a midline longitudinal incision was made. The vertebrae to be fused were identified, and subperiosteal exposure was performed to the tips of the transverse processes. Facet joints were excised, and the transverse processes and laminae were decorticated. After decortication and instrumentation, local autograft with or without bioglass was added. The graft materials were placed in the decorticated area in the same manner in both groups.
After surgery, patients were allowed a gradual return to full activity without external bracing except when thoracoplasty had been associated. Physical therapy was initiated on postoperative day 2 to begin early mobilization and ambulation. Intraoperative and postoperative complications were recorded.
Postoperative follow-up for a minimum of 2 years was required for inclusion in the study. All patients had standing full-length anteroposterior and lateral radiographs of the spine obtained before surgery, immediately after surgery, and at subsequent follow-up visits. In addition, supine bending films, traction radiographs, or both were performed preoperatively to assess curve reducibility.
The stability and success of spinal fusion were assessed by history, examination, and radiography. Radiographic parameters included Cobb angle of the main thoracic curve, main thoracic curve reducibility, curve type according to King_s and Lenke_s classifications, frontal balance (distance in millimeters between the center of T1 and the center sacral line), and T9 sagittal offset.
Demographic data and preoperative radiographic parameters were compared between the 2 groups using an unpaired t test and the Mann-Whitney U test. The Cobb angle measurement of the fused segments on the initial postoperative radiograph was compared with the Cobb angle measurement at final follow-up to assess loss of correction. Loss of correction and sagittal balance between immediate postoperative and latest follow-up were compared using an unpaired t test and the Mann-Whitney U test. A P G 0.05 was considered significant.
RESULTS

Demographics of the Study Groups
Among the 88 consecutive AIS operated on, 40 patients received iliac crest autograft and 48 received bioactive glass. No patient was lost to follow-up. Demographics of each group are listed in Table 1 . Mean follow-up period was 40 months in the autograft group (range, 24Y84 months) and 38 months in the bioactive glass group (range, 25Y52 months). No statistical difference was found between the groups.
Preoperative Radiographic Parameters
Preoperative radiographic parameters of the 2 study groups are reported in Table 2 . No statistical difference was found in any of the parameters between the 2 groups. The number of patients who underwent thoracoplasty and who subsequently had brace postoperatively was not significant between the 2 groups.
Complications
In the autograft group, there were 2 infections (5%) and 3 mechanical failures (7.5%) at the proximal portion of the construct. Bone formation was not assessed by computed tomography, but these 3 pseudarthroses were associated with loss of correction and proximal junctional kyphosis. No mechanical failure was observed at the thoracolumbar junction. One of the latter failures required a revision procedure because of disabling pain and progressive loss of frontal balance. Instrumentation was removed from 2 other patients (5%) who complained of pain. Intraoperative verification revealed that fusion had been achieved with no pseudarthrosis. Three patients (7.5%) still complained of donor site pain at latest follow-up.
One infection (2%) occurred in the bioglass group. One early mechanical failure (2%) was observed and required a revision procedure. The cause was a technical error with initial misplacement of a proximal hook.
Mechanical failures were excluded from the rest of the analysis.
Blood Loss
Blood loss averaged 853 (T240) mL in the bioglass group and 1280 (T370) mL in the autograft group. The difference was statistically significant (P = 0.02).
Fused Levels, Loss of Correction, Sagittal Balance
The number of levels fused averaged 12.1 (T1.8) in the autograft group and 11.8 (T2) in the bioglass group. The difference was not significant. The distal level of fusion in the autograft group was L2 in 16 cases, L3 in 16 cases, and L4 in 8 cases. In the bioglass group, the last instrumented level was L2 in 18 cases, L3 in 19 cases, and L4 in 11 cases. All patients had fusion of the thoracolumbar junction.
Radiographic parameters of the 2 study groups at latest follow-up are presented in Table 3 . Loss of correction of the main thoracic curve between immediate postoperative and latest follow-up averaged 15.5% for the autograft group and 11% for the bioglass group (Fig. 2) . The difference was statistically significant (P = 0.025). The loss of correction averaged 1.9 (T3.7) degrees in the bioactive glass group and 3.7 (T3.0) degrees in the autograft group.
At latest follow-up, the T9 sagittal offset was not significantly different between the 2 groups (P = 0.15).
DISCUSSION
The results of this study suggest that spinal fusion using bioactive glass as bone substitute to complete local autograft achieves results similar to those obtained using autologous iliac crest bone graft in patients with AIS. In addition, fewer complications and less loss of correction were observed postoperatively in the bioglass group.
Considered the gold standard in spinal fusion, iliac crest bone graft is very effective in augmenting bone healing. In providing osteogenic precursors cells, it is osteoinductive and osteoconductive. However, harvesting of iliac crest graft is associated with numerous complications including bleeding, neurovascular injury, gait disturbance, fracture, pain, and cosmetic problems. 7, 8 Major complications have been reported in 10% and minor complications in 39% of patients who undergo an iliac crest bone graft. Donor site pain is the most common complication, with reported incidence rates as high as 29%. 9 In a series of children, Skaggs et al 10 reported pain severe enough to interfere with daily activity in 15% at 4-year follow-up. These limitations have led to the use of Several studies have demonstrated the efficacy of allograft for AIS. 12, 13 However, results are controversial for adult spine fusion, and costs remain high.
14 In addition, banked allograft bone is not often available in our country, and the risk of disease transmission with fresh and fresh-frozen allograft is not negligible.
In contrast to allograft bone, DBM has osteoconductive and osteoinductive properties. In one clinical study in which DBM was used as an isolated graft material, a lower fusion rate was observed compared with that obtained with autologous bone graft. 15 In contrast, stable fusion was achieved in patients operated on for AIS when DBM was associated with bone marrow. 11 This difference is probably due to osteogenic precursor cells and growth factors introduced by the addition of bone marrow. 16 Some authors have also reported satisfactory results with synthetic porous ceramic, but this technique is relatively costly. 17 Recently, there has been keen interest in the use of osteoinductive agents, including bone morphogenetic proteins for spinal fusion. OP-1 (or BMP-7) is one such agent and has been shown to speed the rate of bone healing and to improve the performance of autograft in animals. 18 However, few human clinical studies are available. Kanayama et al 1 recently reported that OP-1 reliably induced viable amounts of new bone formation, but their fusion success rate, evaluated by surgical exploration in 7 patients, was only 57%.
The ideal graft material should be biocompatible, bioresorbable, bioconductive, and cost-effective. Bioactive glass is an osteoconductive bone substitute that fulfils these requirements, remodeling to normal bone over time and reducing local inflammatory reactions. 19, 20 Several studies have previously shown that bioglass also exhibits the property of osteostimulation, associated with higher rates of osteoblast activity than hydroxyapatite. 19, 21 Moreover, in studies on oral microorganisms in vitro, bioglass has demonstrated antibacterial properties, which may reduce the potential for bacterial colonization of the sites grafted. 22 In animal studies, mixes of autograft and bioactive glass have produced results comparable to those of autograft alone for nonhealing calvarial defects and spinal fusion. 23, 24 However, to our knowledge, the ability of bioactive glass to achieve spinal fusion in humans has never been reported.
It is now accepted that loss of correction after fusion in AIS can occur during a 2-year follow-up period, mainly during the first postoperative year. Results of spine surgery can be reliably evaluated radiologically after a minimum follow-up of 2 years. 25 Loss of correction after posterior fusion for AIS using CotrelYDubousset or more recent segmental instrumentation varies in the literature between 8% and 28%. 26 In the present series, the difference between Cobb angle measurements on immediate postoperative radiographs and at final follow-up averaged 11% in the bioactive glass group and 15.5% in the autograft group. Blood loss was significantly reduced when bioglass was used. Fewer complications were seen in the bioactive glass group, but the difference did not reach statistical significance, likely due to the small number of cases.
There are several weaknesses in this study. Placement into different study groups was dependent on the type of bone graft being used by the surgeon at that time. Thus, the 2 groups of patients represent a succession in time rather than a randomized study. For that reason, the reduction of blood loss can also be explained by the learning curve of the operating team and the improvement of its technique. All the procedures were performed by a single surgeon, using the same technique for both groups, but the results need to be confirmed in a multicenter study. In addition, the follow-up for the patients was different between the 2 groups. The autograft group had the longest follow-up of 84 months, whereas the bioglass group had follow-up to 52 months. Even though loss of correction mainly occurs during the 2 first postoperative years, one can argue that more pseudarthroses might be reported after longer follow-up. This will need to be further studied at longterm follow-up. Another confounding factor is that although the age at the time of surgery was not different between the 2 groups and that all the patients were operated on after they had their menarche, the exact stage of physiologic maturity at surgery was not investigated. Thus, the eventual role of crankshaft phenomenon in the loss of correction was not evaluated.
In both groups, local autograft was used, mixed with either iliac crest autogenous bone graft or bioactive glass. Violas et al recently showed that in situ local autograft was sufficient to achieve spinal fusion in patients with AIS. They concluded that the association between autograft obtained from spinous processes, laminae and transverse processes, and an adequate fusion technique might obviate the necessity of any additional graft material. 27 Thus, the respective roles of bioglass and in situ local autograft are difficult to distinguish in the spinal fusion achieved in the present series.
Results of this study suggest that bioactive glass can be proposed as an effective bone substitute in the treatment of AIS, avoiding iliac crest harvesting and the related morbidity. However, clinical and radiological outcomes warrant longer term follow-up.
